[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100539937":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":30,"centralContacts":35,"locations":46,"responsibleParty":65,"collaborators":67,"id":69,"slug":70,"hasResults":71,"nctId":72,"briefTitle":73,"officialTitle":74,"acronym":75,"eligibilityCriteria":76,"healthyVolunteers":71,"sex":77,"minAge":78,"maxAge":26,"enrollmentInfo":79,"targetDuration":26,"studyType":82,"phases":83,"briefSummary":85,"conditions":86,"keywords":88,"overallStatus":49,"whyStopped":26,"lastUpdateSubmitDate":93,"lastUpdatePostDateStruct":94,"startDateStruct":97,"completionDateStruct":99,"leadSponsor":101,"locationsCount":102},{"fullName":5,"class":6},"Norwegian University of Science and Technology","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Usual care","ACTIVE_COMPARATOR","Standard of care echocardiographic follow-up",[13],"Diagnostic Test: Comprehensive echocardiographic follow-up",{"label":15,"type":16,"description":17,"interventionNames":18},"Simplified care","EXPERIMENTAL","Simplified echocardiographic follow-up",[19],"Diagnostic Test: Simplified echocardiographic follow-up",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DIAGNOSTIC_TEST","Comprehensive echocardiographic follow-up","Comprehensive echocardiographic follow-up for identification of CRTCD in breast cancer patients",[9],null,{"type":22,"name":17,"description":28,"armGroupLabels":29,"otherNames":26},"Simplified echocardiographic follow-up for identification of CRTCD in breast cancer patients",[15],[31],{"name":32,"affiliation":33,"role":34},"Espen Holte, MD, PhD","St. Olavs Hospital","PRINCIPAL_INVESTIGATOR",[36,42],{"name":37,"role":38,"phone":39,"phoneExt":40,"email":41},"Espen Holte, MD. PhD","CONTACT","92243119","47","espen.holte@stolav.no",{"name":43,"role":38,"phone":44,"phoneExt":40,"email":45},"Havard Dalen, MD, PhD","95871716","havard.dalen@ntnu.no",[47],{"facility":48,"status":49,"city":50,"state":26,"zip":51,"country":52,"countryCode":53,"cosmosGeoPoint":54,"geoPoint":59,"contacts":60},"St. Olavs hospital","RECRUITING","Trondheim","7491","Norway","NO",{"type":55,"coordinates":56},"Point",[57,58],10.39506,63.43049,{"lat":58,"lon":57},[61],{"name":62,"role":38,"phone":63,"phoneExt":40,"email":64},"Rune Wiseth, MD, PhD","92247845","rune.wiseth@stolav.no",{"type":66,"investigatorFullName":26,"investigatorTitle":26,"investigatorAffiliation":26,"oldNameTitle":26,"oldOrganization":26},"SPONSOR",[68],{"name":33,"class":6},"100539937","trust-ace---anticancer-treatment-cardiotoxicity-identification-by-echocardiography-100539937",false,"NCT06310330","TRUST-ACE - Anticancer-treatment Cardiotoxicity Identification by Echocardiography","Technology Revising Ultrasound Solutions for Tomorrow - Anticancer-treatment Cardiotoxicity Identification by Echocardiography","TRUST-ACE","Inclusion Criteria:\n\n* Breast cancer and referral for follow-up to identify potential CTRCD\n\nExclusion Criteria:\n\n* Not willing or able to consent","ALL","18 Years",{"count":80,"type":81},250,"ESTIMATED","INTERVENTIONAL",[84],"NA","TRUST-ACE will compare a simplified echocardiographic protocol focusing on ventricular function with the guideline recommended comprehensive echocardiographic examination using a randomised design in follow-up of breast-cancer patients with respect to identification of cancer treatment related cardiac dysfunction (CTRCD).\n\nSecondly, the study will evaluate whether novel tools used to improve standardization of recordings as well as automated measurements of central measurements, e.g. ejection fraction (EF) and global longitudinal strain (GLS) can improve the precision of echocardiography in daily clinical practice.",[87],"Breast Neoplasm Malignant Primary",[89,90,91,92],"echocardiography","breast cancer","artificial intelligence","cardiotoxicity","2025-06-05",{"date":95,"type":96},"2025-06-06","ACTUAL",{"date":98,"type":96},"2024-03-08",{"date":100,"type":81},"2026-12-31",{"name":5,"class":6},1]